Qianqian Zhu

ORCID: 0000-0003-2542-2827 · 6 papers in corpus · active 2018-2025

Study types

  • article 3
  • letter 1
  • other 1
  • rct 1

Condition tags

  • endometriosis 4
  • infertility 1
  • endometrioma 1
other 2025
Retraction Note: The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial
Reproductive health ·doi:10.1186/s12978-025-01977-4
article 2024
Semiconducting polymer nanoparticles laden with platelet-rich plasma for endometrium regeneration via regulating macrophage M1/M2 type polarization
·doi:10.1016/j.apmt.2024.102409
article 2023
Metabolomics analysis of follicular fluid in ovarian endometriosis women receiving progestin-primed ovary stimulation protocol for in vitro fertilization
Scientific reports ·doi:10.1038/s41598-023-32797-w

This study aimed to investigate the metabolite profile and inflammatory state of follicular fluid (FF) in women with stage III-IV ovarian endometriosis (OE) who underwent in vitro fertilization (IVF). A cohort of 20 consecutive patients wit…

rct 2022
The comparison of two different protocols ultra-long versus medroxyprogesterone acetate in women with ovarian endometriosis: a prospective randomized controlled trial
Reproductive health ·doi:10.1186/s12978-022-01500-z

BACKGROUND: This study aimed to investigate the medroxyprogesterone acetate (MPA) + HMG protocol vs ultra-long gonadotrophin releasing hormone (GnRH) agonist protocol in patients with advanced ovarian endometriosis who received in vitro fer…

article 2020
Impacts of medroxyprogesterone acetate on oocytes and embryos: matched case-control study in women with stage III–IV ovarian endometriosis undergoing controlled ovarian hyperstimulation for in vitro fertilization
Annals of translational medicine ·doi:10.21037/atm.2020.02.15

BACKGROUND: This study investigated the effects of medroxyprogesterone acetate (MPA) on the oocytes and embryos in patients with advanced endometriosis who had a normal ovarian reserve and tubal infertility and received controlled ovarian h…

letter 2018
REPLY: The ‘Big Freeze’: freeze-all should not be used for everyone
·doi:10.1093/humrep/dey219